• 13 DE
• 14 EN

• 9 Home
• 10 Contact
• 11 Sitemap

• 2 Company
  • 2.1 Philosophy
  • 2.2 Facts and Figures
  • 2.3 Management Board
  • 2.4 History
  • 2.5 Merz Pharmaceuticals
  • 2.6 Merz Consumer Care
  • 2.7 Merz Dental
  • 2.8 Merz Hygiene
  • 2.9 Merz Pharma Group
  • 2.10 Locations

Facts and Figures

Headquarters:	Frankfurt am Main, Germany
Branch Offices:	Germany, Great Britain, France, Italy, Spain, Switzerland, Austria, USA, Mexico, Russia, Canada
Status:	Private company
Fiscal Year:	July 1 - June 30

Key Figures of the Merz Group
		2008/09	2007/08	Change in %
Sales	EUR million	589.8	546.5	7.9
of which:
Pharmaceuticals	EUR million	475.9	427.9	11.2
Consumer Products	EUR million	113.9	118.6	-4.0
of which:
Germany	EUR million	187.8	177.0	6.1
Rest of Europe	EUR million	164.4	155.1	6.0
America	EUR million	220.8	199.5	10.7
Other regions	EUR million	16.8	14.9	12.8
Performance
EBIT	EUR million	135.9	134.7	0.9
EBIT-margin	%	23.0	24.6
Earnings before income taxes	EUR million	133.8	136.3	-1.8
Net income	EUR million	89.6	93.7	-4.4
Operating cash flow	EUR million	144.7	140.0	3.4
Research and development
Research and development expenses	EUR million	132.0	87.1	51.5
In % of sales	%	22.4	15.9
of which: Pharmaceuticals	EUR million	128.5	84.2	52.6
Financial position
Investments	EUR million	26.8	28.3	-5.3
Depreciation and amortization	EUR million	10.4	8.0	30.0
Balance sheet total	EUR million	551.4	441.8	24.8
Employees
Number of employees as of balance sheet date		1,745	1,619	7,8

Download Annual Report

Most Important Products of Merz Pharmaceuticals:

• Axura® (Alzheimer’s)
• PK-Merz® (Parkinson’s)
• Solvex® (depression)
• Contractubex® / Mederma® (scars)
• Naftin® (fungal diseases)
• Pantogar® / Pantovigar® (hair loss)
• Pantostin® (hair loss)
• Hyal-System® (wrinkles)
• Belotero® (wrinkles)
• Hepa-Merz® (liver-related brain impairment)
• Lipo-Merz retard® (lipid metabolism disorders)
• Xeomin® (Blepharospasm; cervical dystonia of a predominantly rotational form)
• Bocouture® (wrinkles)

Most Important Consumer Care Brands:

• tetesept® (OTC drugs)
• Merz Spezial® (beauty care)

Shareholders´council:

• Dr. Jochen Hückmann

Merz Management Board (MMB):

• Dr. Martin Zügel, Chairman of the Management Board
• Hartmut Erlinghagen
• Dr. Matthias A. Vogt

Supervisory Board:

• Edward R. Roberts, Chairman
• Michael Freiherr von Truchseß, assistant Chairman
• Prof. Dr. Dr. h.c. Rolf Krebs
• Prof. Dr. Harald Wiedmann

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

Broschures

• Merz Annual Reports

German Websites

• Alzheimer´s
• Depression
• Dystonia
• Hair Loss
• Hyal-System
• Liver Disease
• Parkinson´s